Organization
Tuebingen, Germany
2 abstracts
Abstract
EGFR expression and relapse in patients with melanoma receiving adjuvant PD-1-based immunotherapy.Org: Skin Cancer Center, University Hospital Leipzig, Department of Dermatology, Eberhard Karls University of Tuebingen, Tübingen, Germany, Kantonsspital St. Gallen,
Abstract
Interim analysis of MelaRisk, a biomarker assay validation study in stage IB/IIA melanoma tissue.Org: Center for Dermatooncology, Department of Dermatology, Eberhard Karls University of Tuebingen, Tuebingen, Germany, Tübingen, Germany,